- Home
- STRO vs ATLO Comparison
STRO vs ATLO Comparison
Compare STRO & ATLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STRO
- ATLO
- Stock Information
- Founded
- STRO 2003
- ATLO 1903
- Country
- STRO United States
- ATLO United States
- Employees
- STRO N/A
- ATLO N/A
- Industry
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- ATLO Major Banks
- Sector
- STRO Health Care
- ATLO Finance
- Exchange
- STRO Nasdaq
- ATLO Nasdaq
- Market Cap
- STRO 147.6M
- ATLO 166.6M
- IPO Year
- STRO 2018
- ATLO N/A
- Fundamental
- Price
- STRO $1.77
- ATLO $18.29
- Analyst Decision
- STRO Strong Buy
- ATLO
- Analyst Count
- STRO 7
- ATLO 0
- Target Price
- STRO $12.14
- ATLO N/A
- AVG Volume (30 Days)
- STRO 950.7K
- ATLO 15.8K
- Earning Date
- STRO 03-24-2025
- ATLO 01-24-2025
- Dividend Yield
- STRO N/A
- ATLO 4.37%
- EPS Growth
- STRO N/A
- ATLO N/A
- EPS
- STRO N/A
- ATLO 1.14
- Revenue
- STRO $160,955,000.00
- ATLO $54,221,000.00
- Revenue This Year
- STRO N/A
- ATLO N/A
- Revenue Next Year
- STRO N/A
- ATLO N/A
- P/E Ratio
- STRO N/A
- ATLO $16.04
- Revenue Growth
- STRO 230.90
- ATLO 3.70
- 52 Week Low
- STRO $1.51
- ATLO $15.69
- 52 Week High
- STRO $6.13
- ATLO $22.03
- Technical
- Relative Strength Index (RSI)
- STRO 42.89
- ATLO 56.73
- Support Level
- STRO $1.76
- ATLO $18.24
- Resistance Level
- STRO $1.95
- ATLO $18.62
- Average True Range (ATR)
- STRO 0.13
- ATLO 0.32
- MACD
- STRO 0.00
- ATLO -0.03
- Stochastic Oscillator
- STRO 41.94
- ATLO 78.85
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers.
About ATLO Ames National Corporation
Ames National Corporation is a United States-based bank holding company. Through its subsidiaries, it provides checking, savings and time deposits, cash management services, merchant credit card processing, safe deposit boxes, wire transfers, direct deposit of payroll and social security checks, and automated/video teller machine access. Its loan portfolio comprises commercial, residential & agricultural real estate loans; agricultural & business operating loans & lines of credit; equipment loans; vehicle loans; personal loans; and mortgage loans. Its operations are conducted in central, north central, and south-central Iowa.